We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

95 hedge funds and large institutions have $123M invested in Cytokinetics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $2.99M | Put options by funds: $1M

18% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 28

6% less funds holding

Funds holding: 101 → 95 (-6)

13% less capital invested

Capital invested by funds: $141M → $123M (-$17.7M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
95
Holders Change
-6
Holders Change %
-5.94%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
33
Reduced
28
Closed
23
Calls
$2.99M
Puts
$1M
Net Calls
+$1.99M
Net Calls Change
-$1.49M

Top Buyers

1
BI
BVF Inc
California
+$4.27M
2
TC
TFS Capital
Pennsylvania
+$2.99M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.2M
4
BA
BlackRock Advisors
Delaware
+$1.77M
5
Deutsche Bank
Deutsche Bank
Germany
+$983K

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.9M
2
BIM
Bogle Investment Management
Massachusetts
-$3.38M
3
Millennium Management
Millennium Management
New York
-$2.05M
4
Morgan Stanley
Morgan Stanley
New York
-$802K
5
GACM
Green Arrow Capital Management
New York
-$757K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$15.4M +$4.27M +650,000 +38%
LPLP
2
Lansdowne Partners Limited Partnership
United Kingdom
$13.1M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$12.2M +$137K +20,781 +1%
BIT
4
BlackRock Institutional Trust
California
$6.16M +$410K +62,392 +7%
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.19M +$600K +91,345 +13%
BFA
6
BlackRock Fund Advisors
California
$4.72M -$141K -21,433 -3%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$4.64M +$346K +52,700 +8%
Millennium Management
8
Millennium Management
New York
$3.6M -$2.05M -312,401 -36%
TC
9
TFS Capital
Pennsylvania
$3.6M +$2.99M +455,746 +467%
IIM
10
Ironwood Investment Management
Massachusetts
$3.57M +$338K +51,414 +10%
Deutsche Bank
11
Deutsche Bank
Germany
$3.23M +$983K +149,587 +43%
IG
12
ING Group
Netherlands
$2.75M – – –
State Street
13
State Street
Massachusetts
$2.68M +$227K +34,523 +9%
Northern Trust
14
Northern Trust
Illinois
$2.29M +$89.1K +13,569 +4%
Renaissance Technologies
15
Renaissance Technologies
New York
$2.18M +$2.2M +335,267 New
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$2.15M – – –
Principal Financial Group
17
Principal Financial Group
Iowa
$2.07M +$30.9K +4,700 +2%
Allianz Asset Management
18
Allianz Asset Management
Germany
$1.92M – – –
BA
19
BlackRock Advisors
Delaware
$1.86M +$1.77M +269,501 +1,580%
WA
20
Wasatch Advisors
Utah
$1.65M +$675K +102,787 +68%
PAI
21
Palo Alto Investors
California
$1.51M -$189K -28,736 -11%
TCIM
22
TIAA CREF Investment Management
New York
$1.43M +$581K +88,400 +67%
IGIM
23
I.G. Investment Management
Manitoba, Canada
$1.41M +$670K +102,000 +89%
Connor, Clark & Lunn Investment Management (CC&L)
24
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.4M +$744K +113,193 +127%
CA
25
Commerzbank Aktiengesellschaft
Germany
$1.39M +$470K +71,608 +66%
1
2 3 4 5

CYTK Hedge Fund Activity: Q4 2013 in Review

95 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2013, worth a combined $123M — down 13% from $141M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of CYTK and 17 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 33 added.

The largest buyer was BVF Inc, adding an estimated $4.27M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $10.9M sold.

  • 95 institutional investors held Cytokinetics (CYTK) as of Q4 2013, down from 101 in Q3 2013.
  • Funds reported $123M of Cytokinetics stock for Q4 2013, down 13% quarter-over-quarter.
  • 17 funds opened new Cytokinetics positions in Q4 2013 and 23 closed out, a net change of -6 holders.
  • The largest Cytokinetics buyer in Q4 2013 was BVF Inc, an estimated $4.27M added.
  • The largest Cytokinetics seller in Q4 2013 was T. Rowe Price Associates, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2013.